Quad/Graphics, Inc. (QUAD)
NYSE: QUAD · Real-Time Price · USD
6.23
-0.26 (-4.01%)
Aug 8, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts that cover Ligand Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $9.30, which forecasts a 49.28% increase in the stock price over the next year. The lowest target is $8.60 and the highest is $10.
Price Target: $9.30 (+49.28%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ligand Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $10 | Buy | Maintains | $10 | +60.51% | Jul 31, 2025 |
| Rosenblatt | Rosenblatt | Strong Buy Maintains $8.9 → $8.6 | Strong Buy | Maintains | $8.9 → $8.6 | +38.04% | Jul 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $10 | Buy | Maintains | $10 | +60.51% | Jul 29, 2025 |
| Rosenblatt | Rosenblatt | Strong Buy Maintains $8.9 | Strong Buy | Maintains | $8.9 | +42.86% | Jun 6, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $10 | Buy | Maintains | $10 | +60.51% | May 2, 2025 |
Financial Forecast
Revenue This Year
2.47B
from 2.67B
Decreased by -7.60%
Revenue Next Year
2.41B
from 2.47B
Decreased by -2.39%
EPS This Year
0.96
from -1.07
EPS Next Year
1.07
from 0.96
Increased by 10.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 2.6B | 2.5B |
| Avg | 2.5B | 2.4B |
| Low | 2.4B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -4.4% | 1.2% |
| Avg | -7.6% | -2.4% |
| Low | -11.7% | -6.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 1.05 | 1.26 |
| Avg | 0.96 | 1.07 |
| Low | 0.87 | 0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 30.7% |
| Avg | - | 10.6% |
| Low | - | -9.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.